Guidance on the licensing of biosimilar products
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Health And Social Care
Published
May 6, 2021
Last updated
November 7, 2022
Description
This guideline is to provide developers of biosimilar products with a clear outline of the requirements in Great Britain.
Tags
Organization
Country / Region
United Kingdom
License
Open Government Licence 2.0 (United Kingdom)